CREBBP loss drives immune evasion by epigenetically silencing STING and MHC-I in small cell lung cancer
Most small cell lung cancers (SCLCs) exhibit low immunogenicity and intrinsic resistance to immunotherapy, yet the underlying mechanisms remain poorly understood. Here, we identify CREBBP loss, a frequent genetic alteration in SCLC, as a key suppressor ...